Neal Shore, MD, FACS, discussed a study on survival outcomes in metastatic castration-sensitive prostate cancer comparing ...
Following the clearance of an investigational new drug application from the FDA, a phase 1 trial will examine the novel ...
Mass spectrometry and machine learning show promise for early cancer detection and prognosis by analyzing metabolic signatures.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback